Pharmafile Logo

Unleashing Creativity in Virtual Pharma Engagements

Think outside the box with virtual engagements! Discover how creative asynchronous touchpoints can revolutionize your interactions. Explore everything from OLAs to treatment pathway profiling via a pharma-compliant virtual platform.

Explore the boundless potential of asynchronous touchpoints with our final tip in the series. Learn how creativity can redefine the scope and impact of your virtual interactions on the Impetus InSite Platform®.

10. Be Creative
Step beyond traditional advisory boards and team meetings. The Impetus InSite Platform® offers a versatile canvas for engaging participants in innovative ways. Whether it’s through Online Learning Activities (OLAs), journal clubs, case study discussions, post-(virtual) conference debriefs, patient journey mapping, or treatment pathway profiling, there’s a multitude of creative possibilities to explore. Embrace the flexibility of asynchronous touchpoints to craft unique and compelling engagement experiences that captivate and educate your participants.

This tip encourages you to think outside the box and discover new ways to leverage virtual tools for enhanced communication and deeper insight gathering.

For more creative strategies and insights into maximizing your virtual engagements, check out our blog: https://www.impetusdigital.com/2020/05/12/top-10-tips-for-optimizing-asynchronous-virtual-meetings/

Elevate your virtual engagements with Impetus Digital:

Stay connected for more creative ideas and updates:

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

The 5 W’s of Virtual Patient Engagement

Learn the Who, What, When, Where, and Why (+ How) of virtual patient engagement programs...

How to Increase Engagement During Virtual Events

Tip #4 - How do you plan the agenda for your virtual event?We suggest to invite participant input to build and personalize the engagement.Invite participant input and rethink your agenda...

Engaging KOLs & Gaining Insights in Pharma’s New Normal

Kaitlin Anstett, Senior Medical Advisor at Theratechnologies, shares her unique insights into the way Medical Affairs teams are changing the way they are engaging and interacting with their most important...

Mobilizing Agitation Detection in Children with ADHD

Marius Rus, founder of StressLess–the startup behind Tully–discusses wearable technologies for children with ADHD, autism, and other mental health conditions. He also shares his tips and lessons learned from founding...

How to Increase Engagement During Virtual Events

Tip #4 - How do you plan the agenda for your virtual event? We suggest to invite participant input to build and personalize the engagement. Check out our full top...

How Pharma, Payers, & Providers are Leveraging Patient Self-Management Platforms

Rick Anderson, President of DarioHealth, explores digital therapeutics, how DarioHealth is utilizing #ai and behavioral science to personalize each user’s health journey, and how this approach can help improve #diversity...

How the Legally Blind Can Achieve Enhanced Vision

Roland Mattern, Director of Product Marketing at eSight Eyewear, shares how eSight’s technologies are being used to bring sight back to people living with central vision loss. He also discusses...

Boost engagement during virtual events and meetings

Tip #7 - How do you increase engagement during virtual events? Make it fun! ️ See all Top 10 tips: https://www.impetusdigital.com/2021/03/25/top-10-tips-to-increase-engagement-during-virtual-events/ To learn more, visit us at http://impetusdigital.com/Book a demo today http://www.meetwithimpetus.com/ 

How to Increase Engagement During Virtual Events

Here's tip 8 of 10 on how to increase engagement during virtual events. Learn more tips at  https://www.impetusdigital.com/2021/03/25/top-10-tips-to-increase-engagement-during-virtual-events/ To find out more about how Impetus Digital can aid pharma and life...

The (inevitable) digital transformation of Medical Affairs

It’s not a question of ‘if,’ it’s a question of ‘when.’